Aquamantys® System and Transcollation® Technology - Medel
  • No tags were found...

Aquamantys® System and Transcollation® Technology - Medel

Aquamantys ® Systemand Transcollation ® TechnologyOVERVIEWThe Aquamantys System delivers patented Transcollation technology to stop bleeding and reduce blood loss duringand after surgery. 1-4 Transcollation technology is a combination of radiofrequency (RF) energy and saline that provideshemostatic sealing of soft tissue and bone. It has been clinically shown to lower transfusion rates and may reduce theneed for other blood management products during or after surgery. 1,2HOW IT WORKSTranscollation® technology integrates RF energyand saline to deliver controlled thermal energy totissue. The coupling of saline and RF energy allowsthe device temperature to stay at approximately100°C – nearly 200°C less than conventional devices.This produces a tissue effect without the associatedcharring found in other methods.Hemostatic Sealing of Soft Tissue andBone to Reduce Blood LossStep 1RF energy and saline is applied to tissueStep 2Heat-induced shrinkage occursStep 3Vessels

Transcollation ® TechnologyDuring SurgeryTotal hip arthroplasty images provided by John Keggi, MDSmall bleeding vessel encountered duringdissection of soft tissueTranscollation technology is appliedto tissueReferences1. Performance has not been specifically established in all procedures.2. Geller DA, Tsung A, et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB, 2005; 7:208-213.3. Marulanda GA, Ulrich SD, et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5:125-131.4. Marulanda GA, Krebs VE, et al. Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. American Journal of Orthopedics 2009; 38(12):E179-183.5. Mankin KP, Moore CA, Miller LE, Block JE. Hemostasis with a bipolar sealer during surgical correction of adolescent idiopathic scoliosis. E-published in Journal of SpinalDisorders & Techniques, October 2011. doi:10.1097/BSD.0b013e3182334ec5.6. Performance has not been specifically established with the Aquamantys System.7. Bierbaum BE, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2-10.Caution: Federal Law (USA) restricts these devices to sale by or on the order of a physician. For a listing of indications, contraindications, precautions, and warnings, please refer to theInstructions For Use (IFU) that accompany Aquamantys disposable devices and/or the Aquamantys System User Guide.For further information, please call 866-777-9400.You may also consult our Advanced Energy, LLCMedtronic USA, Inc.180 International DrivePortsmouth, NH (866) 777-9400Fax: (866) 222-0900Shrinkage of tissue stops the bleeding© 2011, Medtronic, Inc. All rights reserved. Aquamantys®, the Aquamantys® logo and Transcollation® are registered trademarks of Medtronic, Inc.71-10-1422 11.11 Rev E

More magazines by this user
Similar magazines